Literature DB >> 2807764

Effect of calcium ion on analgesia of opioid peptides.

J F Wang1, S P Han, Z Lu, X J Wang, J S Han, M F Ren.   

Abstract

The analgesic effect produced by subcutaneous injection (SC) of morphine was antagonized by intracerebroventricular (ICV) but not intrathecal (ITH) injection of CaCl2. While ITH CaCl2 was devoid of any effect on the analgesia induced by ITH morphine, it did antagonize the analgesic effect produced by ITH injection of dynorphin A or (D-Pen2,D-Pen5)-enkephalin (DPDPE). In accordance with this, the uptake of 45Ca by synaptosomes prepared from the dorsal column of rat spinal cord was suppressed by dynorphin A or DPDPE, but not by morphine. The results imply that different kinds of opioid ligands might have different mechanisms of action at discrete areas of the CNS. Blockade of neuronal Ca2+ uptake may serve as an important mechanism for morphine analgesia in the brain as well as DPDPE and dynorphin A analgesia in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807764     DOI: 10.3109/00207458908987440

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  The analgesic effect of trans-resveratrol is regulated by calcium channels in the hippocampus of mice.

Authors:  Weijie Wang; Yingcong Yu; Jing Li; Lin Wang; Zhi Li; Chong Zhang; Linlin Zhen; Lianshu Ding; Gang Wang; Xiaoyang Sun; Ying Xu
Journal:  Metab Brain Dis       Date:  2017-06-12       Impact factor: 3.584

2.  Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.

Authors:  Jian-Hui Liang; Xu-Hua Wang; Rui-Ke Liu; Hong-Lei Sun; Xiang-Feng Ye; Ji-Wang Zheng
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

3.  Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells.

Authors:  L J Zhang; X Y Lu; J S Han
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.